Combatting antibiotic resistant bacteria (CARB) program

Ended Definitive Contract Awarded

Contract number
75F40122C00180
Awardee
Awarding agency
Obligated
$291,618

Award facts

Contract value 100% obligated
$291,618.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Cost No Fee
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration awarded a $291,618 definitive contract to Institute For Clinical Pharmacodynamics, Inc. for the Combatting Antibiotic Resistant Bacteria (CARB) program on September 21, 2022, on a cost no-fee basis with no set-aside.

Place of performance is Silver Spring, MD. The contract ultimate completion date is September 29, 2023. The originating work covers pharmacometric research and modernized susceptibility guidance development in support of FDA antimicrobial stewardship initiatives.

Quick answers

Who was awarded contract 75F40122C00180?

75F40122C00180 was awarded to Institute For Clinical Pharmacodynamics, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 21, 2022.

How much is contract 75F40122C00180 worth?

The government has obligated $291,618 on 75F40122C00180.

Was contract 75F40122C00180 competed?

The extent of competition for 75F40122C00180 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award